CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carr, A. S.
Right arrow Articles by Britt, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carr, A. S.
Right arrow Articles by Britt, B. A.

Canadian Journal of Anesthesia, Vol 42, 281-286, Copyright © 1995 by Canadian Anesthesiologists' Society

ARTICLES

Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy

AS Carr, J Lerman, M Cunliffe, ME McLeod and BA Britt
Department of Anaesthesia, Hospital for Sick Children, Toronto, Ontario.

To determine the incidence of malignant hyperthermia (MH) reactions after trigger-free anaesthesia in a large population of MH-susceptible (MHS) patients, the charts of 2,214 patients who underwent elective muscle biopsy for malignant hyperthermia were reviewed. Either general or regional anaesthesia with non-triggering drugs was used. For general anaesthesia, the trachea was intubated in the absence of muscle relaxants. The halothane/caffeine contracture test was performed on the biopsied muscle. Suspected MH reactions were identified according to their site of occurrence (in the operating room, recovery room or ward). Ninety-seven percent of patients received a general anaesthetic; 3% received a regional anaesthetic or field block. Of the 2214 patients whose muscles were biopsied, 1082 patients were biopsy-positive for MH. Five patients in whom MH reactions were diagnosed in the recovery room were all subsequently proved to be biopsy-positive for MH. Four of the five received intravenous dantrolene as part of their therapy; the fifth received only symptomatic therapy as parenteral dantrolene was not commercially available. All patients recovered completely from their reactions. We conclude that the incidence of MH reactions in biopsy-positive patients who receive a trigger-free anaesthetic for minor surgery is small (0.46%, (0.15-1.07%, 95% CI)). These reactions occur in the immediate postoperative period.


This article has been cited by other articles:


Home page
 Canadian J. AnesthesiaHome page
G. L. Bryson, F. Chung, R. G. Cox, M.-J. Crowe, J. Fuller, C. Henderson, B. A. Finegan, Z. Friedman, D. R. Miller, J. van Vlymen, et al.
Patient selection in ambulatory anesthesia - An evidence-based review: part II: [La selection des patients en anesthesie ambulatoire - Une revue factuelle : partie II]
Can J Anesth, October 1, 2004; 51(8): 782 - 794.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
Z. Friedman, F. Chung, and D. T. Wong
Ambulatory surgery adult patient selection criteria - a survey of Canadian anesthesiologists: [La selection des patients adultes en chirurgie ambulatoire - enquete aupres des anesthesiologistes]
Can J Anesth, May 1, 2004; 51(5): 437 - 443.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Canadian Anesthesiologists' Society.